Stephen Feider - 31 Jan 2025 Form 4 Insider Report for Beta Bionics, Inc. (BBNX)

Role
Chief Financial Officer
Signature
/s/ Stephen Feider
Issuer symbol
BBNX
Transactions as of
31 Jan 2025
Net transactions value
$0
Form type
4
Filing time
03 Feb 2025, 20:30:08 UTC
Previous filing
29 Jan 2025
Next filing
03 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBNX Employee Stock Option (right to buy) Award $0 +166,542 $0.000000 166,542 31 Jan 2025 Common Stock 166,542 $7.51 Direct F1, F2
transaction BBNX Employee Stock Option (right to buy) Award $0 +109,695 $0.000000 109,695 31 Jan 2025 Common Stock 109,695 $5.10 Direct F2, F3
transaction BBNX Employee Stock Option (right to buy) Award $0 +186,203 $0.000000 186,203 31 Jan 2025 Common Stock 186,203 $17.00 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares subject to this option shall vest one year after August 1, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.
F2 Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.
F3 The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.
F4 Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts.